您的购物车当前为空
Antileukinate is a synthetic hexapeptide with an acetylated amino terminus and an amidated carboxyl terminus that inhibits the binding of CXC chemokines to the chemokine receptor CXCR2. It inhibits IL-8 binding to neutrophils (Ki = 2.7-13 μM), prevents neutrophil chemotaxis and β-glucuronidase release, and blocks IL-8-induced skin edema in rabbits. At 53 mg/kg, antileukinate has been shown to protect mice against acute pancreatitis and associated lung injury.

Antileukinate is a synthetic hexapeptide with an acetylated amino terminus and an amidated carboxyl terminus that inhibits the binding of CXC chemokines to the chemokine receptor CXCR2. It inhibits IL-8 binding to neutrophils (Ki = 2.7-13 μM), prevents neutrophil chemotaxis and β-glucuronidase release, and blocks IL-8-induced skin edema in rabbits. At 53 mg/kg, antileukinate has been shown to protect mice against acute pancreatitis and associated lung injury.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 500 μg | ¥ 2,970 | 35日内发货 | |
| 1 mg | ¥ 5,780 | 35日内发货 | |
| 5 mg | ¥ 22,600 | 35日内发货 |
Antileukinate 相关产品
| 产品描述 | Antileukinate is a synthetic hexapeptide with an acetylated amino terminus and an amidated carboxyl terminus that inhibits the binding of CXC chemokines to the chemokine receptor CXCR2. It inhibits IL-8 binding to neutrophils (Ki = 2.7-13 μM), prevents neutrophil chemotaxis and β-glucuronidase release, and blocks IL-8-induced skin edema in rabbits. At 53 mg/kg, antileukinate has been shown to protect mice against acute pancreatitis and associated lung injury. |
| 分子量 | 1003.19 |
| 分子式 | C45H66N18O7S |
| CAS No. | 138559-60-1 |
| Sequence Short | Ac-RRWWCR-NH2 |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| 溶解度信息 | DMF: 1 mg/mL (1 mM), Sonication is recommended. PBS (pH 7.2): 2 mg/mL (1.99 mM), Sonication is recommended. DMSO: 5 mg/mL (4.98 mM), Sonication is recommended. | ||||||||||
溶液配制表 | |||||||||||
DMF/PBS (pH 7.2)/DMSO
| |||||||||||
评论内容